کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
5621831 | 1579193 | 2017 | 8 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Cost-effectiveness of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation at high risk of bleeding and normal kidney function
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
موضوعات مرتبط
علوم پزشکی و سلامت
پزشکی و دندانپزشکی
کاردیولوژی و پزشکی قلب و عروق
پیش نمایش صفحه اول مقاله
![عکس صفحه اول مقاله: Cost-effectiveness of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation at high risk of bleeding and normal kidney function Cost-effectiveness of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation at high risk of bleeding and normal kidney function](/preview/png/5621831.png)
چکیده انگلیسی
For patients with creatinine clearance between 50 and 95Â ml/min, apixaban 5Â mg was the most cost-effective treatment for willingness-to-pay thresholds (WTP) above $115,000/QALY gained, and edoxaban 60Â mg was cost-effective when the WTP was between $75,000 and $115,000/QALY gained. For patients with creatinine clearance >Â 95Â ml/min, apixaban 5Â mg was the most cost-effective treatment for WTP thresholds above $80,000/QALY gained.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Thrombosis Research - Volume 150, February 2017, Pages 123-130
Journal: Thrombosis Research - Volume 150, February 2017, Pages 123-130
نویسندگان
Inmaculada PharmD, PhD, Kenneth J. MD, MS, Yuting PhD,